Literature DB >> 27717711

BET bromodomain is a novel regulator of TAZ and its activity.

Qiong Duan1, Yi Xiao1, Lingyan Zhu2, Zhenzhen Liu1, Xiaoxiao Mao3, Zhengxiang Zhou1, Chaonan Liao4, Jinxing Cai4, Fulian Huang5, Zehao Liu6, Jian Zeng7, Ke Xia1, Cheng Chang8, Jun Qi9, Zihua Chen10, He Huang11, Tianlun Yang12.   

Abstract

Transcriptional coactivator with PDZ-binding motif (TAZ) is a key transcriptional mediator of Hippo signaling that has been recently reported to mediate Wnt-activated transcription and serve as a component to suppress canonical Wnt/β-catenin activity. The Bromodomain and Extra-terminal domain (BET) family of proteins can recognize the acetylated lysine chain on histones and plays a critical role in transcriptional regulation. However, the mechanisms underlying transcriptional repression by the BET bromodomain are poorly understood. Here, we found that BET bromodomain inhibition upregulated TAZ protein and its transcriptional output, independent of its well-established role as a mediator of Hippo and Wnt signaling. Additionally, JQ1, a synthetic BET inhibitor, suppressed Wnt/β-catenin activity by upregulating TAZ. Although JQ1 upregulated TAZ, which is known to promote cell proliferation, it drastically suppressed the growth of colon cancer cells by inducing cell cycle arrest. Collectively, our study identified an unexpected transcriptional repression function of the BET bromodomain and a novel mechanism for TAZ upregulation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bromodomain and extra-terminal domain protein (BET); Colon cancer; TAZ; β-Catenin

Mesh:

Substances:

Year:  2016        PMID: 27717711     DOI: 10.1016/j.bbagrm.2016.10.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  TNKS inhibitors potentiate proliferative inhibition of BET inhibitors via reducing β-Catenin in colorectal cancer cells.

Authors:  Qian Wu; Yi-Fei Xuan; Ai-Ling Su; Xu-Bin Bao; Ze-Hong Miao; Ying-Qing Wang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Knowledge base and emerging trends in YAP1 research.

Authors:  Rong Xu; Zhiying Yang; Jiahui Fan; Xueying Huang; Linna Long; Siying Yu; Xiaorui Zhang; Xia Li; He Huang
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

3.  TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC.

Authors:  Stacy Grieve; Gabriel Wajnberg; Miranda Lees; Simi Chacko; Jackson Weir; Nicolas Crapoulet; Tony Reiman
Journal:  Blood Adv       Date:  2019-11-26

4.  Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.

Authors:  Yun-Long Shen; He-Zhen Li; Yan-Wei Hu; Lei Zheng; Qian Wang
Journal:  CNS Neurosci Ther       Date:  2018-10-18       Impact factor: 5.243

Review 5.  Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis.

Authors:  Altynbek Zhubanchaliyev; Aibar Temirbekuly; Kuralay Kongrtay; Leah C Wanshura; Jeannette Kunz
Journal:  Front Pharmacol       Date:  2016-12-01       Impact factor: 5.810

6.  Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1.

Authors:  Tim-Michael Decker; Michael Kluge; Stefan Krebs; Nilay Shah; Helmut Blum; Caroline C Friedel; Dirk Eick
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

Review 7.  A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.

Authors:  Dong-Guk Shin; Dashzeveg Bayarsaihan
Journal:  Yale J Biol Med       Date:  2017-03-29

8.  The mevalonate coordinates energy input and cell proliferation.

Authors:  Li Gong; Yi Xiao; Fan Xia; Pei Wu; Tingting Zhao; Shulin Xie; Ran Wang; Qiaocheng Wen; Wensu Zhou; Huilan Xu; Lingyan Zhu; Zeqi Zheng; Tianlun Yang; Zihua Chen; Qiong Duan
Journal:  Cell Death Dis       Date:  2019-04-11       Impact factor: 8.469

9.  Human cathelicidin antimicrobial peptide suppresses proliferation, migration and invasion of oral carcinoma HSC-3 cells via a novel mechanism involving caspase-3 mediated apoptosis.

Authors:  Xi Chen; Shenying Ji; Jia Si; Xiangyu Zhang; Xiaoyan Wang; Yong Guo; Xianqiong Zou
Journal:  Mol Med Rep       Date:  2020-10-23       Impact factor: 2.952

10.  Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications.

Authors:  Yan-Jun Wan; Li-Xi Liao; Yang Liu; Heng Yang; Xiao-Min Song; Li-Chao Wang; Xiao-Wen Zhang; Yi Qian; Dan Liu; Xiao-Meng Shi; Li-Wen Han; Qing Xia; Ke-Chun Liu; Zhi-Yong Du; Yong Jiang; Ming-Bo Zhao; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.